#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Autocrine Regulation of Pulmonary Inflammation by Effector T-Cell Derived IL-10 during Infection with Respiratory Syncytial Virus


Respiratory syncytial virus (RSV) infection is the leading viral cause of severe lower respiratory tract illness in young infants. Clinical studies have documented that certain polymorphisms in the gene encoding the regulatory cytokine IL-10 are associated with the development of severe bronchiolitis in RSV infected infants. Here, we examined the role of IL-10 in a murine model of primary RSV infection and found that high levels of IL-10 are produced in the respiratory tract by anti-viral effector T cells at the onset of the adaptive immune response. We demonstrated that the function of the effector T cell -derived IL-10 in vivo is to limit the excess pulmonary inflammation and thereby to maintain critical lung function. We further identify a novel mechanism by which effector T cell-derived IL-10 controls excess inflammation by feedback inhibition through engagement of the IL-10 receptor on the antiviral effector T cells. Our findings suggest a potentially critical role of effector T cell-derived IL-10 in controlling disease severity in clinical RSV infection.


Vyšlo v časopise: Autocrine Regulation of Pulmonary Inflammation by Effector T-Cell Derived IL-10 during Infection with Respiratory Syncytial Virus. PLoS Pathog 7(8): e32767. doi:10.1371/journal.ppat.1002173
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002173

Souhrn

Respiratory syncytial virus (RSV) infection is the leading viral cause of severe lower respiratory tract illness in young infants. Clinical studies have documented that certain polymorphisms in the gene encoding the regulatory cytokine IL-10 are associated with the development of severe bronchiolitis in RSV infected infants. Here, we examined the role of IL-10 in a murine model of primary RSV infection and found that high levels of IL-10 are produced in the respiratory tract by anti-viral effector T cells at the onset of the adaptive immune response. We demonstrated that the function of the effector T cell -derived IL-10 in vivo is to limit the excess pulmonary inflammation and thereby to maintain critical lung function. We further identify a novel mechanism by which effector T cell-derived IL-10 controls excess inflammation by feedback inhibition through engagement of the IL-10 receptor on the antiviral effector T cells. Our findings suggest a potentially critical role of effector T cell-derived IL-10 in controlling disease severity in clinical RSV infection.


Zdroje

1. GlezenWPTaberLHFrankALKaselJA 1986 Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140 543 546

2. ShayDKHolmanRCNewmanRDLiuLLStoutJW 1999 Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282 1440 1446

3. PeeblesRSJrGrahamBS 2005 Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2 110 115

4. CollinsPLGrahamBS 2008 Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82 2040 2055

5. OshanskyCMZhangWMooreETrippRA 2009 The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol 4 279 297

6. MalleyRDeVincenzoJRamiloODennehyPHMeissnerHC 1998 Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 178 1555 1561

7. MooreKWde Waal MalefytRCoffmanRLO'GarraA 2001 Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 683 765

8. CouperKNBlountDGRileyEM 2008 IL-10: the master regulator of immunity to infection. J Immunol 180 5771 5777

9. LiMOFlavellRA 2008 Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28 468 476

10. SunJMadanRKarpCLBracialeTJ 2009 Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med. 15 277 284

11. GentileDADoyleWJZeeviAHowe-AdamsJKapadiaS 2003 Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol 64 338 344

12. HoebeeBBontLRietveldEvan OostenMHodemaekersHM 2004 Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J Infect Dis 189 239 247

13. WilsonJRowlandsKRockettKMooreCLockhartE 2005 Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis. J Infect Dis 191 1705 1709

14. MiyairiIDeVincenzoJP 2008 Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 21 686 703

15. ChangJBracialeTJ 2002 Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 8 54 60

16. MadanRDemircikFSurianarayananSAllenJLDivanovicS 2009 Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 183 2312 2320

17. HuffordMMKimTSSunJBracialeTJ 2011 Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med 208 167 180

18. SzaboSJKimSTCostaGLZhangXFathmanCG 2000 A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 655 669

19. FontenotJDRudenskyAY 2005 A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 6 331 337

20. CannonMJOpenshawPJAskonasBA 1988 Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 168 1163 1168

21. GrahamBSBuntonLAWrightPFKarzonDT 1991 Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88 1026 1033

22. LiuFWhittonJL 2005 Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J Immunol 174 5936 5940

23. PilsMCPisanoFFasnachtNHeinrichJMGroebeL 2010 Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur J Immunol 40 443 448

24. KochMATucker-HeardGPerdueNRKillebrewJRUrdahlKB 2009 The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10 595 602

25. RuckwardtTJBonaparteKLNasonMCGrahamBS 2009 Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol 83 3019 3028

26. FultonRBMeyerholzDKVargaSM 2010 Foxp3+ CD4 Regulatory T Cells Limit Pulmonary Immunopathology by Modulating the CD8 T Cell Response during Respiratory Syncytial Virus Infection. J Immunol 185 2382 2392

27. LeeDCHarkerJATregoningJSAtabaniSFJohanssonC 2010 CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol 84 8790 8798

28. DonnellyRPDickensheetsHFinbloomDS 1999 The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19 563 573

29. SieweLBollati-FogolinMWickenhauserCKriegTMullerW 2006 Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur J Immunol 36 3248 3255

30. MuraiMTurovskayaOKimGMadanRKarpCL 2009 Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10 1178 1184

31. BrooksDGWalshKBElsaesserHOldstoneMB 2010 IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Proc Natl Acad Sci U S A 107 3018 3023

32. BiswasPSPedicordVPlossAMenetELeinerI 2007 Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. J Immunol 179 4520 4528

33. ComminsSSteinkeJWBorishL 2008 The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121 1108 1111

34. LeggJPHussainIRWarnerJAJohnstonSLWarnerJO 2003 Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 168 633 639

35. BennettBLGarofaloRPCronSGHosakoteYMAtmarRL 2007 Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis 195 1532 1540

36. JunttiHOsterlundPKokkonenJDunderTRenkoM 2009 Cytokine responses in cord blood predict the severity of later respiratory syncytial virus infection. J Allergy Clin Immunol 124 52 58 e51-52

37. HussellTSpenderLCGeorgiouAO'GarraAOpenshawPJ 1996 Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol 77 Pt 10 2447 2455

38. BartzHBuning-PfaueFTurkelOSchauerU 2002 Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin Exp Immunol 129 438 445

39. JarttiTPaul-AnttilaMLehtinenPParikkaVVuorinenT 2009 Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: an observational study. Respir Res 10 85

40. ShireyKAPletnevaLMPucheACKeeganADPrinceGA 2010 Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol 3 291 300

41. TregoningJSYamaguchiYHarkerJWangBOpenshawPJ 2008 The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J Virol 82 4115 4124

42. LawrenceCWBracialeTJ 2004 Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 173 1209 1218

43. SunJPearceEJ 2007 Suppression of early IL-4 production underlies the failure of CD4 T cells activated by TLR-stimulated dendritic cells to differentiate into Th2 cells. J Immunol 178 1635 1644

44. YangZSharmaAKLindenJKronILLaubachVE 2009 CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg 137 695 702 discussion 702

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#